Literature DB >> 12217944

GABAergic mechanisms of opiate reinforcement .

Zheng-Xiong Xi1, Elliot A Stein.   

Abstract

The neurobiological mechanisms of opiate-induced reinforcement are still not completely understood. Over the past two decades, the vast majority of studies have focused on the role of the mesolimbic dopamine (DA) system. However, current studies strongly suggest that opiate actions on gamma-aminobutyric acid (GABA)-ergic cells in both the ventral tegmental area (VTA) and the nucleus accumbens (NAcc) appear to play critical roles. In this review, we focus on the neurochemical substrates of opiate reinforcement and review the role of DA and non-DA substrates, including opioid, GABA, glutamate and serotonin on opiate-reinforced behaviour and the activity of dopaminergic and GABAergic neurons in the VTA and the NAcc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217944     DOI: 10.1093/alcalc/37.5.485

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  29 in total

1.  Kindling modifies morphine, cocaine and ethanol place preference.

Authors:  Axel Becker; Marco Schmitz; Gisela Grecksch
Journal:  Exp Brain Res       Date:  2005-08-11       Impact factor: 1.972

2.  Loss of BDNF signaling in D1R-expressing NAc neurons enhances morphine reward by reducing GABA inhibition.

Authors:  Ja Wook Koo; Mary Kay Lobo; Dipesh Chaudhury; Benoit Labonté; Allyson Friedman; Elizabeth Heller; Catherine Jensen Peña; Ming-Hu Han; Eric J Nestler
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

3.  Effects of acute ethanol on beta-endorphin release in the nucleus accumbens of selectively bred lines of alcohol-preferring AA and alcohol-avoiding ANA rats.

Authors:  Minh P Lam; Harri Nurmi; Noora Rouvinen; Kalervo Kiianmaa; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2009-11-26       Impact factor: 4.530

4.  Deficits in neuronal cytochrome P450 activity attenuate opioid analgesia but not opioid side effects.

Authors:  Lindsay B Hough; Julia W Nalwalk; Rachel A Cleary; James G Phillips; Cheng Fang; Weizhu Yang; Xinxin Ding
Journal:  Eur J Pharmacol       Date:  2014-07-22       Impact factor: 4.432

Review 5.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

6.  Electrical stimulation mPFC affects morphine addiction by changing glutamate concentration in the ventral tegmental area.

Authors:  Asal Keramatian; Hojjatallah Alaei; Akram Eidi; Maryam Radahmadi
Journal:  Metab Brain Dis       Date:  2019-05-21       Impact factor: 3.584

7.  Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Vadim Yuferov; Peter Blanken; Jan M van Ree; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2017-12-06       Impact factor: 2.533

8.  Self-administration of the GABAA agonist muscimol into the medial septum: dependence on dopaminergic mechanisms.

Authors:  Stéphanie Gavello-Baudy; Julie Le Merrer; Laurence Decorte; Vincent David; Pierre Cazala
Journal:  Psychopharmacology (Berl)       Date:  2008-08-01       Impact factor: 4.530

9.  Periaqueductal gray afferents synapse onto dopamine and GABA neurons in the rat ventral tegmental area.

Authors:  Natalia Omelchenko; Susan R Sesack
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

10.  Roles of dopaminergic innervation of nucleus accumbens shell and dorsolateral caudate-putamen in cue-induced morphine seeking after prolonged abstinence and the underlying D1- and D2-like receptor mechanisms in rats.

Authors:  Jun Gao; Yonghui Li; Ning Zhu; Stephen Brimijoin; Nan Sui
Journal:  J Psychopharmacol       Date:  2012-11-13       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.